KCAS Bio today announced that its European site in Lyon, France, has successfully renewed its Statement of Compliance with Good Laboratory Practices (GLP) according to Directive 2004/9/CE (safety ...
A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...
ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world's first GMP-validated adventitious viral agent (AVA) ...
GLP-1 RAs are prescribed to about 20% of potentially eligible adolescents, with increasing odds based on several individual factors.
Twenty percent of potentially eligible youth are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), with the ...
Serena Williams' Super Bowl commercial for GLP-1s and the telehealth company Ro has been met with criticism online after it ...
Hims & Hers is downgraded to hold as the 40% rally after Novo Nordisk’s dismissal of its lawsuit is likely driven by a short ...
Hims & Hers Health is facing existential risk as regulatory uncertainty and margin erosion undermine its growth narrative. Click here to read why HIMS is a Sell.
First-in-class solution consolidates multiple assays into a single test, enabling broader viral detection, faster time-to-result and more confident decision-making in regulated biopharmaceutical ...
Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now.
Health influencers promise an astonishing range of benefits from peptides, almost none of them tested in humans ...
Russell Crowe previously discussed how he lost 55 pounds with the help of the Ways2Well program. Here's what to know.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results